Article
Population Pharmacokinetics Study of Morinidazole in Patients with Moderate Hepatic Impairment
2018-05-02
Abstract excerpt
<h4>Objective</h4> Morinidazole is a novel third generation 5-nitroimidazole antimicrobial drug which has demonstrated substantial antibacterial activity against clinical isolates of anaerobe. The aim of this study was to build population pharmacokinetic (PPK) model of morinidazole among patients with hepatic impairment and to provide dosage adjustment strategy for morinidazole in patients with hepatic impairment...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3b9d502b-da2e-56f6-b224-2f9ca409636f
- DOI
- 10.1101/312728
